📑Vajstavu izbuves darbi
Procurement process summary
This process is to purchase Vajstavu izbuves darbi.
This contract was awarded by 🇱🇻 VSIA „Paula Stradiņa klīniskā universitātes slimnīca” for an amount of EUR 40,000 to 1 supplier. It was published on 2023-03-28 through not reported
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇱🇻 VSIA „Paula Stradiņa klīniskā universitātes slimnīca” Buying unitnot reported Publication date2023-03-28 Contest statusnot reported DescriptionVajstavu izbuves darbiAwards
This award was granted to Sabiedrība ar ierobežotu atbildību "Guliver" by VSIA „Paula Stradiņa klīniskā universitātes slimnīca” for an amount of EUR 40,000. The procurement process was conducted through Not available for the category of Not available. The award was granted on 2023-04-24. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇱🇻 Sabiedrība ar ierobežotu atbildību "Guliver" | EUR 40,000 | 2023-04-24 | 1 |
Market context and opportunities
The execution of this contract allows the entity VSIA „Paula Stradiņa klīniskā universitātes slimnīca” to fulfill its public service objectives efficiently.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberLV_ocds-70d2nz-ae9d91d3-56de-4c27-ba92-1f67b3850fc1-award-1Publication date2023-03-28Contract datenot reportedAward date2023-04-24CategoriesPurchase modalitynot reportedMethod detailsnot reportedStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
